NCT02287350View on ClinicalTrials.gov

Pharmacokinetics & Safety of Diclofenac Potassium Oral Solution in Ped. Subjects (2-12 Yrs) With Mild-Mod. Acute Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Pain
Interventions
DRUG

diclofenac potassium oral solution

Administration of diclofenac potassium oral solution, taken by mouth, as needed for mild to moderate acute pain.

Trial Locations (5)

Unknown

Sheffield

Stanford

City of Saint Peters

Dallas

Milwaukee

Sponsors

Lead Sponsor

Depomed
All Listed Sponsors
lead

Depomed

INDUSTRY

NCT02287350 - Pharmacokinetics & Safety of Diclofenac Potassium Oral Solution in Ped. Subjects (2-12 Yrs) With Mild-Mod. Acute Pain | Biotech Hunter | Biotech Hunter